Yong Bao

1.3k total citations
60 papers, 780 citations indexed

About

Yong Bao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Yong Bao has authored 60 papers receiving a total of 780 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 30 papers in Pulmonary and Respiratory Medicine and 19 papers in Surgery. Recurrent topics in Yong Bao's work include Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Treatments and Mutations (11 papers). Yong Bao is often cited by papers focused on Lung Cancer Diagnosis and Treatment (13 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Treatments and Mutations (11 papers). Yong Bao collaborates with scholars based in China, United States and Hong Kong. Yong Bao's co-authors include Ming Chen, Fang Peng, Ying Luo, Chong Zhao, Fang Peng, Zhen‐Yu He, Lixia Lu, Xiao Hu, Qiang Li and Shao-Xiong Wu and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Yong Bao

55 papers receiving 769 citations

Peers

Yong Bao

PRM

ONCOL

SURGE

Wendong Gu China

Yi‐Jun Hua China

L. Arribas Spain

Barbara Vischioni Italy

Shiliang Liu China

Yi-Jun Hua China

Kristina H. Young United States

Hai‐Qiang Mai China

Tamara Rordorf Switzerland

Dong-Hua Luo China

Wendong Gu China

Yong Bao

255 ×0.8

PRM

243 ×0.8

ONCOL

283 ×1.2

192 ×0.9

SURGE

272 ×1.4

Citations per year, relative to Yong Bao Yong Bao (= 1×) peers Wendong Gu

Countries citing papers authored by Yong Bao

Since Specialization

Citations

This map shows the geographic impact of Yong Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong Bao more than expected).

Fields of papers citing papers by Yong Bao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong Bao. The network helps show where Yong Bao may publish in the future.

Co-authorship network of co-authors of Yong Bao

This figure shows the co-authorship network connecting the top 25 collaborators of Yong Bao. A scholar is included among the top collaborators of Yong Bao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong Bao. Yong Bao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oh, D-Y., Han Sun, Jae‐Weon Kim, et al.. (2024). 134O Asia subgroup overall survival and long-term follow-up results of the phase IIb HERIZON-BTC-01 study: Zanidatamab in previously treated human epidermal growth factor receptor 2 (HER2)-amplified biliary tract cancer (BTC). Annals of Oncology. 35. S1453–S1453. 1 indexed citations

Lv, Junwei, et al.. (2024). The Influence of Pelvic Bone Dose-volume Parameters on Bone Marrow Suppression During Radiation Therapy in Patients With Stage I to III Rectal Cancer Based on Real-world Data. Advances in Radiation Oncology. 10(1). 101662–101662. 1 indexed citations

Hu, Xiao, et al.. (2024). Six versus four or five cycles of first‐line etoposide and platinum‐based chemotherapy combined with thoracic radiotherapy in patients with limited‐stage small‐cell lung cancer: A propensity score‐matched analysis of a prospective randomized trial. Cancer Medicine. 13(8). e7215–e7215. 1 indexed citations

Chen, Yan, et al.. (2023). Role of dynamic contrast-enhanced MRI in predicting severe acute radiation-induced rectal injury in patients with rectal cancer. European Radiology. 34(3). 1471–1480. 2 indexed citations

Wu, Qing, Mengyuan Chen, Fang Peng, et al.. (2023). A study of the prognosis of patients with limited-stage small cell lung cancer who did or did not receive prophylactic cranial irradiation after effective chemoradiotherapy. Frontiers in Oncology. 13. 1118371–1118371. 3 indexed citations

Peng, Fang, Yujin Xu, Yong Bao, et al.. (2021). Five-year survival rate analysis: the combination of fortnightly-administration of endostar and concurrent chemoradiotherapy versus concurrent chemoradiotherapy in the treatment of inoperable locally advanced non-small cell lung cancer. Annals of Palliative Medicine. 10(7). 7560–7570. 7 indexed citations

Xiao, Weiwei, Xiaohao Wang, Haiyang Chen, et al.. (2020). Colorectal cancer under 20 years old: a retrospective analysis from three tertiary hospitals. Journal of Cancer Research and Clinical Oncology. 147(4). 1145–1155. 7 indexed citations

Peng, Fang, Qiang Li, Guo-Ping Shen, et al.. (2019). ZWINT is the next potential target for lung cancer therapy. Journal of Cancer Research and Clinical Oncology. 145(3). 661–673. 25 indexed citations

Yang, Xing‐Li, Yan Wang, Yong Bao, et al.. (2018). Additional Cervical Lymph Node Biopsy is Not a Significant Prognostic Factor for Nasopharyngeal Carcinoma in the Intensity-Modulated Radiation Therapy Era: A Propensity Score-matched Analysis from an Epidemic Area. Journal of Cancer. 9(16). 2844–2851. 3 indexed citations

10.

Yang, Xin, Zhen‐Yu He, Xiaobo Jiang, et al.. (2017). Development and application of MOSAIQ integration platform based on radiotherapy workflow. Zhonghua fangshe zhongliuxue zazhi. 26(8). 918–923. 2 indexed citations

11.

He, Zhen‐Yu, San‐Gang Wu, Fang Peng, et al.. (2016). Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT. Translational Oncology. 10(1). 1–9. 38 indexed citations

12.

Wang, Jin, Yuan Yuan Chen, A. Tai, et al.. (2015). Sensorineural Hearing Loss after Combined Intensity Modulated Radiation Therapy and Cisplatin-Based Chemotherapy for Nasopharyngeal Carcinoma. Translational Oncology. 8(6). 456–462. 23 indexed citations

13.

Xu, Zhonghua, Yang Dong, Fang Peng, et al.. (2015). Pigment epithelium-derived factor enhances tumor response to radiation through vasculature normalization in allografted lung cancer in mice. Cancer Gene Therapy. 22(4). 181–187. 8 indexed citations

14.

Wu, San‐Gang, Fang Peng, Juan Zhou, et al.. (2015). Number of Negative Lymph Nodes Can Predict Survival after Postmastectomy Radiotherapy According to Different Breast Cancer Subtypes. Journal of Cancer. 6(3). 261–269. 7 indexed citations

15.

Peng, Fang, Zumin Xu, Jin Wang, et al.. (2012). Recombinant Human Endostatin Normalizes Tumor Vasculature and Enhances Radiation Response in Xenografted Human Nasopharyngeal Carcinoma Models. PLoS ONE. 7(4). e34646–e34646. 56 indexed citations

16.

Wang, Jin, Fang Peng, Li Zhang, et al.. (2012). Severe acute radiation pneumonitis after concurrent chemoradiotherapy in non-small cell lung cancer. Zhonghua fangshe zhongliuxue zazhi. 21(4). 326–329. 1 indexed citations

17.

Bao, Yong, Xiao Hu, Yan Wang, et al.. (2012). A prospective phase I / II study of recombinant endostatin (Endostar) combined with concurrent radio-chemotherapy in patients with unresectable stage III non-small cell lung cancer. Zhonghua fangshe zhongliuxue zazhi. 21(6). 500–503. 1 indexed citations

18.

Zhao, Chong, Jin Wang, Yuan Liu, et al.. (2011). Intensity‐modulated radiation therapy reduces radiation‐induced trismus in patients with nasopharyngeal carcinoma. Cancer. 117(13). 2910–2916. 57 indexed citations

19.

Peng, Fang, Jin Wang, Yi Zou, & Yong Bao. (2011). Recombinant human endostatin improves tumor vasculature and alleviates hypoxia in Lewis lung carcinoma. Zhonghua fangshe zhongliuxue zazhi. 20(1). 69–72. 2 indexed citations

20.

Chen, Ming, Yuanyuan Chen, Yong Bao, et al.. (2005). Neoadjuvant Chemotherapy Followed by Late-Course Accelerated Hyperfractionated Radiation Therapy for Locally Advanced Non–Small-Cell Lung Cancer: Long-Term Results of a Phase I/II Clinical Trial. Clinical Lung Cancer. 6(5). 304–309. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact